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Objective: The study investigated whether childhood cognitive ability moderates Type 2 diabetes
polygenic risk manifestation in older age. Method: In 940 relatively healthy people (mean age
69.55  0.85), we tested whether self-reported diabetes and hemoglobin HbA1c (HbA1c) levels
were predicted by diabetes polygenic risk, cognitive ability measured about 60 years earlier, and
their interaction. Polygenic risk scores aggregated the small effects of up to nearly 121,000
single-nucleotide polymorphisms (SNPs). Participants’ cognitive ability was measured at age 11.
Results: Both polygenic risk and low childhood cognitive ability significantly predicted diabetes
diagnosis. Polygenic risk interacted with cognitive ability (p  .02), predicting HbA1c levels more
strongly in people with below-median cognitive ability (effect r  .21) than in people with
above-median cognitive ability (effect r  .10). The interaction term was not significant for
self-reported diabetes (p  .34), although the genetic risk-diabetes association showed a tendency
of being stronger among those with below-median cognitive ability. Conclusions: Higher premorbid
cognitive ability may provide some environmental protection against the manifestation of Type 2
diabetes genetic risk. This information may improve early identification of diabetes risk and inform
intervention development.
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The recent increase in the prevalence of diabetes is projected to
continue world-wide (Wild, Roglic, Green, Sicree, & King, 2004),
underscoring the importance of better understanding its pathogen-
esis and early risk factors. This study investigates whether the
stable behavioral trait of cognitive ability moderates the manifes-
tation of polygenetic risk for Type 2 diabetes in older age.
Type 2 diabetes (T2D) and its diagnostic marker hemoglobin
HbA1c (HbA1c) demonstrate substantial heritability (Almgren et
al., 2011; Simonis-Bik et al., 2008). Genome-wide association
studies (GWAS) have discovered several common genetic variants
that account for about 10% of the total genetic effects on T2D
(Morris et al., 2012). For the rest, a large number of common
variants, or variants in linkage disequilibrium with those on geno-
typing chips, may be implicated, with each having effects too
small to be detected by the current GWAS projects (Stahl et al.,
2012). Given this possibility, however, existing GWAS data can be
used to quantify polygenic risk for such complex diseases by
aggregating the (often statistically nonsignificant by conventional
standards) small effects of thousands of variants (cf. Davies et al.,
2011; Purcell et al., 2009; Yang et al., 2010).
Yet, probably not everyone genetically predisposed to T2D
develops the condition. Pointing to gene-environment interactions
(Franks, Pearson, & Florez, 2013), T2D genetic risk may be
moderated by dietary habits (Nettleton et al., 2010; Qi, Cornelis,
Zhang, van Dam, & Hu, 2009) and physical activity may interact
with the genetic risk of obesity, a T2D precursor (Andreasen et al.,
2008; Kilpeläinen et al., 2011). Here, we take a more general view
by considering the moderating role of general cognitive ability, a
factor possibly underlying diabetes-prone lifestyle choices (Deary,
Weiss, & Batty, 2010). Lower childhood cognitive ability predicts
diabetes-related outcomes such as metabolic syndrome (Batty et
al., 2008), obesity (Batty, Deary, Schoon, & Gale, 2007a), and
inflammation (Luciano, Marioni, Gow, Starr, & Deary, 2009), as
well as later diabetes itself (Olsson, Hulting, & Montgomery,
2008). These links may be mediated by lifestyle choices, as lower
cognitive ability is associated with smoking (Taylor et al., 2003),
poorer diet and less physical activity (Batty, Deary, Schoon, &
Gale, 2007b), and less persistent adhering to medical treatment
(Deary, Gale, et al., 2009). This is the rationale for hypothesizing
that cognitive ability may also moderate the links between TD2
genetic risk and its actual manifestation. Besides theoretical im-
plications of such a possible moderation, cognitive ability can be
reliably measured many decades before the typical T2D onset age
and may therefore contribute to early identification of people at
risk.
Method
Sample
Almost all of the 1,091 community-dwelling members of the
Lothian Birth Cohort 1936 (LBC1936) sat for an intelligence test
in 1947 (at about age 11) and were followed up between 2004 and
2007. Details on the background, recruitment, and testing proce-
dures are available elsewhere (Deary et al., 2007). The present
study uses data from those 940 LBC1936 members (481 males;
mean age 69.55, SD 0.85) for whom complete data on childhood
cognitive ability, self-reported diabetes, HbA1c, and T2D poly
genetic risk were available. Participants provided written informed
consent. Ethics permissions were obtained from the Multi-Centre
Research Ethics Committee for Scotland.
Measures
Age-11 cognitive ability was measured using the Moray House
Test No. 12 that included word classification, arithmetic and
spatial items, and proverbs. Demonstrating concurrent validity, it
correlated about 0.80 with the Terman-Merrill Revision of the
Binet Test (Deary, Whalley, & Starr, 2009). During follow-up
testing at the clinic, participants were asked about their diabetes
status and their HbA1c levels were measured. Participants were
genome-wide genotyped and their T2D polygenic risk was quan-
tified by combining these data with previously published meta-
analytic results (Morris et al., 2012) on the association between
T2D and nearly 121,000 single-nucleotide polymorphisms (SNPs).
For each participant, the meta-analytic effect size of each SNP’s
“risk” allele was multiplied by the number of copies of the risk
allele carried by the participant. The sums of these individual risks
across all SNPs formed participants’ T2D polygenic risk scores.
For robustness analysis, seven additional risk scores were calcu-
lated by applying increasingly stringent inclusion criteria for
SNPs. See Supplemental Material for further details.
Results
Of the 940 participants, 83 (8.8%) reported diabetes (11 of them
reported insulin therapy, suggesting possible Type 1 diabetes),
whereas 117 (12.4%) had HbA1c levels equal to or above the
cut-off of diabetes diagnosis (The International Expert Committee,
2009). See Supplemental Material for further details and analyses.
Higher T2D polygenic risk significantly predicted self-reported
diabetes (odds ratio per standard deviation increase in predictor
[OR]  1.81, 95% CI [1.40, 2.34], p  .001). People with higher
childhood cognitive ability were less likely to report diabetes
(OR  0.72, 95% CI [0.59, 0.89], p  .001). Higher T2D poly-
genic risk also significantly predicted higher HbA1c levels (stan-
dardized linear regression weights []  .16, 95% CI [.09, .22],
p  .001), as did lower childhood cognitive ability (  .13,
95% CI [.19, .06], p  .001).
The interaction term between childhood cognitive ability and
polygenic risk was statistically nonsignificant (p  .34) when
predicting self-reported diabetes status, but significant (p  .02)
for the prediction of HbA1c. When people were split at median
into those with lower and higher childhood cognitive ability (see
Figure 1), the risk scores predicted HbA1c levels significantly
more strongly in the lower cognitive ability group (  .21, 95%
CI [.11, .31], p  .001) than in the higher ability group (  .10,
95% CI [.01, .19], p  .04; see also Supplemental Material for an
alternative splitting). The nonsignificant interaction in the predic-
tion of self-reported diabetes was in the same direction: the asso-
ciation between genetic risk and diagnosis was stronger in those
below median cognitive ability (OR  1.93, 95% CI [1.38, 2.74],
p  .001) than among those with higher ability (OR  1.64, 95%
CI [1.10, 2.49], p  .05). These findings tended to replicate across
the alternative risk scores based on fewer SNPs (see Supplemental
Material for details). There was little evidence for the association
being driven by participants with potential Type 1 diabetes or by
the use of hypoglycemic drugs (see Supplementary Material for
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details). Finally, we found negligible evidence for the role of body
mass index (BMI) in polygenic risk-diabetes association or in the
polygenic risk-cognitive ability interaction (see Supplemental Ma-
terial for details).
Discussion
The study presented novel evidence for a genetic risk by
stable behavioral trait interaction: polygenic risk for T2D was
more likely to manifest in elevated diabetes marker HbA1c at
age 70 among people with lower childhood cognitive ability
than in those with higher ability test performance nearly 60
years earlier.
There are at least two possible reasons for why the interaction
was not significant, although in the same direction, when self-
reported diabetes diagnosis was used as an outcome. First, with the
sample containing just 83 (8.8%) people with reported diabetes
diagnosis, statistical power to detect a significant interaction for
the binary outcome was limited, whereas the power was higher for
continuously defined HbA1c. Second, diabetes might have been
underdiagnosed in the present sample because the proportion of
people with HbA1c above the cut-off was higher (12.4%) than the
proportion of self-reported diabetes. As a result, self-reported
diabetes could have been a relatively less accurate measure of
actual diabetes status than HbA1c.
By showing that there may be identifiable factors that facilitate
or lessen the links between genetic disease risk and actual disease
phenotype, these findings extend the existing few previous reports
of gene-environment interactions in T2D (Kilpeläinen et al., 2011;
Nettleton et al., 2010; Qi et al., 2009). Low cognitive ability is a
known antecedent of many unhealthy lifestyle choices (Deary et
al., 2010). It is therefore plausible that the mechanisms by which
lower cognitive ability can alter genetic risks include health-
related behaviors such as dietary habits and exercise, and smoking
(Taylor et al., 2003) or health-management (Deary, Gale, et al.,
2009) may also play a role. Also, higher cognitive ability is known
to contribute to educational attainment and, as a result, higher
socioeconomic success (Deary & Johnson, 2010), which may also,
by means of better physical and social environments, lessen the
effects of genetic risk. However, the possible mediating role of
BMI in the polygenic risk-diabetes association (and it being mod-
erated by cognitive ability) was found to be small, suggesting that
the mechanisms by which genetic risk for TD2 manifests itself,
and the moderating role of cognitive ability in these mechanisms,
may be more complex than was proposed above. Thus, although
BMI was measured only concurrently with the diabetes whereas
life-course BMI may have provided more relevant information for
studying diabetes development, the mechanism of how cognitive
ability might facilitate diabetes remain elusive.
The present results have possible practical implications in at
least two important ways. First, to behave in ways that help to
buffer the genetic risks, people do not necessarily have to have
high cognitive ability as such. It may very well suffice if people
with lower cognitive ability mimic what their higher-ability
peers do differently with respect to diabetes-related behaviors.
This is akin to what has previously been termed phenocopying,
whereby an individual’s environmentally produced phenotypic
characteristics are the same as those normally produced by
genetic factors (Deary et al., 2010). The targets of phenocopy-
ing may include dietary habits and exercise but also smoking
and health care habits. Of course, such health lifestyle choices
could and should be encouraged in everyone, regardless of their
cognitive ability levels, which brings us to the second implica-
tion.
Second, it is possible that not all people react to health
interventions in the same way. In particular, it has been sug-
gested that people with lower cognitive ability are less likely to
benefit from different types of public or targeted health inter-
ventions than their cognitively more able peers (Gottfredson,
2004). For example, there is evidence that public campaigns on
various issues are more likely to reach people with higher
education—and therefore, higher cognitive abilities—than peo-
ple with lower education (Weenig & Midden, 1997). As a
result, to the extent that there are specific and potentially
modifiable lifestyle aspects that may facilitate diabetes genetic
risk manifestation, they are likely to operate on people’s
broader cognitive background. It may be useful to factor this
background into any planned interventions. In other words,
although it undeniably is a good idea to promote healthy be-
haviors in all people to buffer against any possible genetic risk
turning into actual disease phenotype, such interventions may
be informed by understanding the antecedents of the behaviors
to be targeted and thereby the barriers that may interfere with
changing them. For example, if and when there are indications
that the people or groups of people to be targeted with an
intervention may have somewhat lower verbal or reasoning
abilities (e.g., low educational level), then the interventions
may need to be delivered in ways that are appropriately tailored.
Our results empirically corroborate that the cognitive back-
ground is indeed relevant in genetic risk manifestation and not
knowing or ignoring this possibility is not likely to benefit
anyone.
Figure 1. The interaction between polygenic risk and childhood cognitive
ability in the prediction of HbA1c.
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For most people, the relative level of cognitive ability is
highly stable across most of the life-course (Deary, Whalley,
Lemmon, Crawford, & Starr, 2000). This means that cognitive
ability level can be used as a predictor of health outcomes at
various points across life-course, including several decades
before the typical onset age of diseases such as T2D (as was
done in this study). Because the same is true for genetic
differences between people, individuals’ cognitive ability and
genetic makeup can be used in combination to more accurately
identify people at higher diabetes risk several decades before
the likely onset age of the disease itself. This may open possi-
bilities for early prevention strategies. Of course, often
cognition-related information may not be readily available, in
which case proxy variables such as school performance or
educational attainment may prove useful.
The findings are potentially informative in terms of diabetes
pathogenesis and prevention but they may also have implications
for the field of genetic risk prediction more generally. Specifically,
it is possible that including behavioral traits such as cognitive
ability may also improve the accuracy of the genetic prediction of
other conditions. From a purely psychological point of view, it is
likewise interesting that a well-established psychological trait may
manifest in people’s lives by moderating how genetic predisposi-
tions for health conditions become manifest. It is possible that such
gene by trait interactions exist for other health phenotypes and
involve other psychological traits as well.
Finally, an important limitation of the study is the sample size,
which was relatively modest for a genetic risk prediction study.
Therefore, these findings should and are intended to be replicated
in larger studies that have relevant information (e.g., the United
Kingdom’s National Child Development Study [the 1958 British
Birth Cohort] or U.K. Biobank).
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